Brief: Oncolys BioPharma to get patent for production method of OBP-601 (Censavudine) in Europe

Oncolys Biopharma

29/08/2016 07:22

Aug 29 (Reuters) - Oncolys BioPharma Inc  4588.T : 
     
    * Says it to receive patent for production method of OBP-601 
(Censavudine) in Europe  
    * Says OBP-601 (Censavudine) is under research and 
development as HIV infection treatment drug 
     
    Source text in Japanese: https://goo.gl/1hWRzf 
    Further company Coverage:  4588.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724; 
Reuters Messaging: qiujing.li.thomsonreuters.com@reuters.net))